Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Phospholipase inhibitors synthesized and tested at Genetics Institute

Sep. 30, 1999

Hydroxamic acid-based inhibitors of TNF-alpha production under study at Yoshitomi

Sep. 30, 1999

New compounds for inflammatory conditions from Genetics Institute act by inhibiting PLA2

Sep. 29, 1999

Celltech reports discovery of alpha4 integrin inhibitors

Sep. 28, 1999

Selective COX-2 inhibitors from UPSA useful for inflammatory and painful conditions

Sep. 28, 1999

Naphthoquinones from Fuji Photo Film exhibit immunosuppressive and antiarthritic activity

Sep. 23, 1999

Genelabs achieves positive results in pivotal trial of GL-701 for treatment of lupus

Sep. 23, 1999

Combination of anti-TNF product and dexamethasone additive or synergistic in arthritic rats

Sep. 22, 1999

New 2-oxoindoles synthesized at Maruho inhibit cytokine production

Sep. 22, 1999

Valentis and Boehringer Ingelheim establish gene medicine collaboration for rheumatoid arthritis

Sep. 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...